The press conference promoted by GSK was held in Milan during which the study conducted by a multidisciplinary team from the Careggi hospital in Florence, made up of immunologists and ENT specialists, was presented, which investigated the role of inflammatory eosinophils in the clinical severity of the severe eosinophilic asthma and the efficacy of the monoclonal antibody mepolizumab as a balancer.
#Gsk #study #presented #Milan #balancing #role #mepolizumab #severe #eosinophilic #asthma
